ChAT IN-1 is a selective Choline Acetyltransferase (ChAT) inhibitor. It can be used to study mechanisms related to the overexpression of non-neuronal ChAT in cancers (e.g., colorectal and lung cancers) and Alzheimer’s disease (AD) [1].
References:
[1]. Baidya ATK, et al. AI-Enabled Ultra-large Virtual Screening Identifies Potential Inhibitors of Choline Acetyltransferase for Theranostic Purposes. ACS Chem Neurosci. 2024 Nov 20;15(22):4156-4170.
References:
[1]. Baidya ATK, et al. AI-Enabled Ultra-large Virtual Screening Identifies Potential Inhibitors of Choline Acetyltransferase for Theranostic Purposes. ACS Chem Neurosci. 2024 Nov 20;15(22):4156-4170.
















